サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臨床試験の世界市場：フェーズ別、疾患別、地域別－予測および分析（2022年～2028年）
市場調査レポート
商品コード
1165269

臨床試験の世界市場：フェーズ別、疾患別、地域別－予測および分析（2022年～2028年）

Global Clinical Trials Market, By Phase, By Disease & By Region- Forecast and Analysis 2022-2028
出版日: | 発行: SkyQuest | ページ情報: 英文 127 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
臨床試験の世界市場：フェーズ別、疾患別、地域別－予測および分析（2022年～2028年）
出版日: 2022年11月30日
発行: SkyQuest
ページ情報: 英文 127 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験の市場規模は2021年の480億7,000万米ドルから、2028年には805億3,000万米ドルに達すると予想され、2022年から2028年までの予測期間中のCAGRは5.9%になると予測されています。様々ながんの適応症を対象とした臨床試験の増加、がん領域の薬剤ポートフォリオに対する研究開発予算は、市場の成長を促進しています。

当レポートでは、世界の臨床試験市場について調査分析し、市場概要、市場規模、市場力学、企業プロファイルなど、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場概要

  • 資料：エグゼクティブサマリー－市場概要の図
  • 資料：エグゼクティブサマリー－市場概要のデータ表
  • 資料：エグゼクティブサマリー－世界の臨床試験市場の特徴に関する図
  • 資料：エグゼクティブサマリー－市場地域：地域別
  • 資料：エグゼクティブサマリー－市場セグメンテーションの図
  • 資料：エグゼクティブサマリー－増分成長の図
  • 資料：エグゼクティブサマリー－増分成長に関するデータ表
  • 資料：エグゼクティブサマリー－ベンダー市場のポジショニングに関する図

親市場分析

市場概要

市場規模

  • 市場力学
    • 資料：DROCの影響分析（2021年）
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • SWOT分析

主要な市場の洞察

  • 技術分析
    • （資料：データ表：技術名と詳細）
  • 価格分析
    • （資料：データ表：技術名と価格詳細）
  • サプライチェーン分析
    • （資料：詳細なサプライチェーンプレゼンテーション）
  • バリューチェーン分析
    • （資料：詳細なバリューチェーンプレゼンテーション）
  • 市場のエコシステム
    • 資料：親市場エコシステムの市場分析
    • 図表：親市場の市場特徴
  • IP分析
    • （資料：データ表：製品・技術名、出願特許、発明者・企業名、取得企業）
  • 貿易分析
    • （資料：データ表：輸出入データの詳細）
  • スタートアップ分析
    • （資料：データ表：新興スタートアップの詳細）
  • 原材料分析
    • （資料：データ表：主要原材料のマッピング）
  • イノベーションマトリックス
    • （資料：ポジショニングマトリックス：新技術と既存技術のマッピング）
  • パイプライン製品分析
    • （資料：データ表：企業名とパイプライン製品、地域別マッピング）
  • マクロ経済指標

新型コロナウイルスの影響

  • イントロダクション
  • 経済シナリオ評価への影響
    • 資料：GDPに関するデータ－前年比成長率（%）（2016年～2022年）
  • 修正された市場規模
    • 資料：世界な臨床試験市場の規模と予測データ表（100万米ドル）（2022年～2028年）
  • COVIDが主要セグメントに与える影響
    • 資料：セグメントの市場規模と予測データ表（100万米ドル）（2022年～2028年）
  • COVID戦略：企業別
    • 資料：企業が採用する主要な戦略に関する分析

市場力学と展望

  • 市場力学
    • 資料：DROCの影響分析（2021年）
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
    • 資料：異なる地域の規制に関するデータ表
  • SWOT分析
  • ポーター分析
    • 競争企業間の敵対関係
  • 図表：競争企業間の敵対関係、主要要因の影響（2021年）
    • 代替品の脅威
  • 図表：代替品の脅威、主要要因の影響（2021年）
    • 買い手の交渉力
  • 図表：買い手の交渉力、主要要因の影響（2021年）
    • 新規参入業者の脅威
  • 図表：新規参入業者の脅威、主要要因の影響（2021年）
    • 供給企業の交渉力
  • 図表：供給企業の交渉力、主要要因の影響（2021年）
  • 将来の混乱に関するSkyquestの特別な洞察
    • 政治的影響
    • 経済的影響
    • 社会的影響
    • 技術的影響
    • 環境的影響
    • 法的影響
  • 世界の臨床試験市場：フェーズ別
  • 世界の臨床試験市場：疾患別

市場規模：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他南米
  • 中東およびアフリカ（MEA）
    • GCC諸国
    • 南アフリカ
    • その他中東およびアフリカ

主な企業プロファイル

  • 競合情勢
  • 資料：調査対象企業（2021年）
  • 資料：企業ポジショニングマトリックス（2021年）
  • 資料：企業の市場シェア、円グラフ分析（%）（2021年）
目次
Product Code: SQSG35A2088

Global Clinical Trials Market was valued at US$ 48.07 billion in 2021, and it is expected to reach a value of US$ 80.53 billion by 2028, at a CAGR of more than 5.9% over the forecast period (2022- 2028).

Clinical trials are a method of conducting clinical research that is governed by a detailed protocol that has been carefully created to address a specific patient care question. Five phases can be used to categorize clinical trials, each of which serves a specific function. Every trial follows a protocol that specifies which people may take part in the study.

Along with describing the duration of the study, trials also detail the precise order of steps, tests, medications, and doses within the study. Since the costs of developing new drugs have significantly increased in recent years, pharma and biotech companies have been searching for modernizations and more efficient ways to run their operations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. 

Segments covered in this report:

Global Clinical trials Market is segmented based on the phase, disease and region. Based on Phases global clinical trials market is segmented into Phase I, Phase II, Phase III, Phase IV. Based on diseases the global clinical trials market is segmented into Autoimmune/Inflammation, Pain management, Oncology, CNS condition, Diabetes, Obesity, Cardiovascular, Others. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

About 30% of all trials were clinical trials for various oncology indications, which also happens to be the therapeutic area with the most drug launches. The majority of the top industry clinical trial sponsors dedicated a sizeable portion of their R&D budget to the oncology drug portfolio.

Non-small cell lung cancer (NSCLC) and breast cancer were primarily targeted for clinical development among the various oncology indications. However, the oncology clinical trial market is steadily becoming more complicated in terms of patient recruitment, clinical trial design elements like endpoints, and more stringent eligibility requirements, among other things.

Restraint

The focus has shifted to genetic and rare diseases, making it difficult to find the right patient population. Additionally, the lack of patient knowledge about clinical trials creates a difficult environment for CROs. The scientific and financial viability could be impacted by improper patient recruitment. The Tufts Center for the Study of Drug Development reports that 11% of clinical trial sites in 2013 were unable to sign up even one patient.

Patient fear of side effects, illiteracy, language barriers for region-specific clinical trials, and documentation of the consent process are additional causes of low patient recruitment.

Market Trends

For businesses in the clinical trials market, the proliferation of digital innovations made possible by wearables and sensors is translating into value-grabbing opportunities. ICON plc, a company that conducts clinical research, is looking into how digital endpoints, such as digital biomarkers, can enhance trial outcomes. As a result, digital health technologies that facilitate sensible device selection and data strategies have been adopted.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Clinical Trials Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Global Clinical Trials Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Global Clinical Trials Market by Phase

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Phase I
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase II
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase III
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Phase IV
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Global Global Clinical Trials Market by Disease

  • Market segments
    • Exhibit: Chart on Market share 2021-2027 (%)
    • Exhibit: Data table on Market share 2021-2027 (%)
  • Autoimmune/Inflammation
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Pain Management
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Oncology
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • CNS Condition
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Diabetes
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Obesity
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Cardiovascular
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
    • Market Estimates & Forecast, 2020-2027
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)